https://orcid.org/0000-0001-5539-5319
Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Melina Gade Sikjær, Andreas Arnholdt Pedersen, Mari Stenvold Wik, Synne Smith Stensholt, Ole Hilberg & Anders Løkke. (2023) Vaccine effectiveness of the pneumococcal polysaccharide and conjugated vaccines in elderly and high-risk populations in preventing invasive pneumococcal disease: a systematic search and meta-analysis. European Clinical Respiratory Journal 10:1.
Read now
Read now
Terapong Tantawichien, Li Yang Hsu, Omer Zaidi, Mark Bernauer, Frieda Du, Eriko Yamada, Jin Oh Kim & Isaya Sukarom. (2022) Systematic literature review of the disease burden and vaccination of pneumococcal disease among adults in select Asia-Pacific areas. Expert Review of Vaccines 21:2, pages 215-226.
Read now
Read now
Bruce A. Mungall, Bernard Hoet, Javier Nieto Guevara & Lamine Soumahoro. (2022) A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children. Expert Review of Vaccines 21:2, pages 201-214.
Read now
Read now
Patricia Izurieta, Michael Scherbakov, Javier Nieto Guevara, Volker Vetter & Lamine Soumahoro. (2022) Systematic review of the efficacy, effectiveness and impact of high-valency pneumococcal conjugate vaccines on otitis media. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Adriana Guzman-Holst, Eliana de Barros, Pilar Rubio, Rodrigo DeAntonio, Otavio Cintra & Ariane Abreu. (2022) Impact after 10-year use of pneumococcal conjugate vaccine in the Brazilian national immunization program: an updated systematic literature review from 2015 to 2020. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Patricia Izurieta & Javier Nieto Guevara. (2022) Exploring the evidence behind the comparable impact of the pneumococcal conjugate vaccines PHiD-CV and PCV13 on overall pneumococcal disease. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Mark Edmondson-Jones, Therese Dibbern, Marcus Hultberg, Bengt Anell, Emma Medin, Yang Feng & Carla Talarico. (2021) The effect of pneumococcal conjugate vaccines on otitis media from 2005 to 2013 in children aged ≤5 years: a retrospective cohort study in two Swedish regions. Human Vaccines & Immunotherapeutics 17:2, pages 517-526.
Read now
Read now
Yara Ruiz García, Javier Nieto Guevara, Patricia Izurieta, Ivo Vojtek, Eduardo Ortega-Barría & Adriana Guzman-Holst. (2021) CIRCULATING CLONAL COMPLEXES AND SEQUENCE TYPES OF STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A WORLDWIDE: THE IMPORTANCE OF MULTIDRUG RESISTANCE: A SYSTEMATIC LITERATURE REVIEW. Expert Review of Vaccines 20:1, pages 45-57.
Read now
Read now
Javier Nieto Guevara & Patricia Izurieta. (2020) Reply to ‘Emergence of Streptococcus pneumoniae serotype 19A (Spn19A) in the pediatric population in Bogotá, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10’. Human Vaccines & Immunotherapeutics 16:9, pages 2307-2308.
Read now
Read now
Nicolas Lecrenier, Alen Marijam, Jan Olbrecht, Lamine Soumahoro, Javier Nieto Guevara & Bruce Mungall. (2020) Ten years of experience with the pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (Synflorix) in children. Expert Review of Vaccines 19:3, pages 247-265.
Read now
Read now
Articles from other publishers (52)
N. N. Kostyukova & V. A. Bekhalo. (2023) Pneumococcal Polysaccharide Conjugated Vaccines and the Problem of Changing Circulating Serotypes of Pneumococcus. Epidemiology and Vaccinal Prevention 22:5, pages 110-120.
Crossref
Crossref
Timothy J. Chapman, Shrita M. Patel, Sheryl A. Flores, Shengjie Xu, Robert Lupinacci, Yaru Shi, Tulin Shekar, Kristen Feemster, Jumi Yi, Gretchen Tamms, Janusz KaminskiKara Bickham, Luwy Musey, Ulrike K. Buchwald & Natalie Banniettis. (2023) Safety and Immunogenicity of V114 in Preterm Infants: A Pooled Analysis of Four Phase Three Studies. Pediatric Infectious Disease Journal 42:11, pages 1021-1028.
Crossref
Crossref
María Eugenia León, Margarita Samudio, Aníbal Kawabata, Minako Nagai, Liliana Rojas, Noemí Zárate, Juan Irala, Myrian Leguizamón, Gloria Gómez, Juana Ortellado, Raquel Blasco, Rossana Franco & Gustavo Chamorro. (2023) Serotypes and antimicrobial resistance of Streptococcus pneumoniae in children under 5 years of age pre- and post-pneumococcal conjugate vaccine introduction in Paraguay. Journal of Medical Microbiology 72:6.
Crossref
Crossref
Janine Paynter, Anna S. Howe, Emma Best & Helen Petousis-Harris. (2023) A retrospective cohort study investigating the comparative effectiveness of pneumococcal vaccines against hospitalisation with otitis media and pneumonia in New Zealand. Vaccine 41:28, pages 4121-4128.
Crossref
Crossref
Shahira Shahid, Muhammad Imran Nisar, Fyezah Jehan, Sheraz Ahmed, Furqan Kabir, Aneeta Hotwani, Sahrish Muneer, Muhammad Farrukh Qazi, Sajid Muhammad, Asad Ali, Anita K.M. Zaidi & Najeeha T. Iqbal. (2023) Co-carriage of Staphylococcus aureus and Streptococcus pneumoniae among children younger than 2 years of age in a rural population in Pakistan. Clinical Epidemiology and Global Health 21, pages 101293.
Crossref
Crossref
Néhémie Nzoyikorera, Idrissa Diawara, Mostafa Katfy, Khalid Katfy, Fakhreddine Maaloum, Joseph Nyandwi, Houria Belabbes, Naima Elmdaghri & Khalid Zerouali. (2023) Serotype distribution and antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates among adult and elderly population before and after introduction of pneumococcal conjugate vaccine in Casablanca, Morocco. BMC Infectious Diseases 23:1.
Crossref
Crossref
Haider N. Dawood, Ali H. Al-Jumaili, Ahmed H. Radhi, Delan Ikram & Ali Al-Jabban. (2023) Emerging pneumococcal serotypes in Iraq: scope for improved vaccine development. F1000Research 12, pages 435.
Crossref
Crossref
Andrea Orsi, Alexander Domnich, Stefano Mosca, Matilde Ogliastro, Laura Sticchi, Rosa Prato, Francesca Fortunato, Domenico Martinelli, Fabio Tramuto, Claudio Costantino, Vincenzo Restivo, Vincenzo Baldo, Tatjana Baldovin, Elizabeth Begier, Christian Theilacker, Eva Agostina Montuori, Rohini Beavon, Bradford Gessner & Giancarlo Icardi. (2022) Prevalence of Pneumococcal Serotypes in Community-Acquired Pneumonia among Older Adults in Italy: A Multicenter Cohort Study. Microorganisms 11:1, pages 70.
Crossref
Crossref
Tianjing Hu, David F. Miller, Amber W. Taylor, Christine Riley, Caitlin McCormick, Keely N. Thomas, Rachel Y. Gao, Kathy L. Rowlen, Emilia B. Byrne, Pardeep Kumar, Soo Kyung Kim & Erica D. Dawson. (2022) 30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization. Vaccines 10:11, pages 1964.
Crossref
Crossref
Montaha AL-Iede, Asim N. Khanfar, Mohammad A. Alshrouf, Muayad I. Azzam, Tala A. Haddad, Omar N. Khanfar, Zaid M. Al-Tarawneh & Shereen M. Aleidi. (2022) Parents’ attitude towards pneumococcal vaccine: an online survey from Jordan. Journal of International Medical Research 50:10, pages 030006052211281.
Crossref
Crossref
Natalie Banniettis, Jacek Wysocki, Leszek Szenborn, Wanatpreeya Phongsamart, Punnee Pitisuttithum, Mika Rämet, Peter Richmond, Yaru Shi, Ron Dagan, Lori Good, Melanie Papa, Robert Lupinacci, Richard McFetridge, Gretchen Tamms, Clay Churchill, Luwy Musey & Kara Bickham. (2022) A phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of catch-up vaccination regimens of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants, children, and adolescents (PNEU-PLAN). Vaccine 40:44, pages 6315-6325.
Crossref
Crossref
Daniel M. Musher, Ronald Anderson & Charles Feldman. (2022) The remarkable history of pneumococcal vaccination: an ongoing challenge. Pneumonia 14:1.
Crossref
Crossref
Hiba Sabbar, Chafik Mahraoui, Magdalena Bastìas Garcià & Imane Jroundi. (2022) Streptococcus pneumoniae vaccination strategies and its expected impact on penicillin non-susceptibility in children under the age of five: Let's recap!. Vaccine: X 11, pages 100170.
Crossref
Crossref
I. Passaris, N. Mauder, M. Kostrzewa, I. Burckhardt, S. Zimmermann, N. M. van Sorge, H.-C. Slotved, S. Desmet & P.-J. Ceyssens. (2022) Validation of Fourier Transform Infrared Spectroscopy for Serotyping of Streptococcus pneumoniae. Journal of Clinical Microbiology 60:7.
Crossref
Crossref
Else M. Bijker, Elizabeth A.L. Bateman, Johannes Trück, Smita Patel & Dominic F. Kelly. (2022) Screening for Immunodeficiencies in Children With Invasive Pneumococcal Disease: Six-year Experience From a UK Children’s Hospital. Pediatric Infectious Disease Journal 41:7, pages 575-578.
Crossref
Crossref
Shahira Shahid, Amala Khan, Muhammad Imran Nisar, Farah Khalid, Muhammad Farrukh Qazi, Sheraz Ahmed, Furqan Kabir, Aneeta Hotwani, Sahrish Muneer, Syed Asad Ali, Cynthia G. Whitney, Anita K. M. Zaidi & Fyezah Jehan. (2022) Pneumococcal Carriage in Infants Post-PCV10 Introduction in Pakistan: Results from Serial Cross-Sectional Surveys. Vaccines 10:6, pages 971.
Crossref
Crossref
Jemima Beissbarth, Heidi C. Smith-Vaughan, Allen C. Cheng, Peter S. Morris & Amanda J. Leach. (2022) BIGDATA: A Protocol to Create and Extend a 25-Year Clinical Trial and Observational Data Asset to Address Key Knowledge Gaps in Otitis Media and Hearing Loss in Australian Aboriginal and Non-Aboriginal Children. Frontiers in Pediatrics 10.
Crossref
Crossref
Paul S Schulz, Sarah E Moore, Daniel Smith, Jessica Javed & Ashley M Wilde. (2022) Missed Pneumococcal Vaccination Opportunities in Adults With Invasive Pneumococcal Disease in a Community Health System. Open Forum Infectious Diseases 9:4.
Crossref
Crossref
Thomas Belcher, Hana Kammoun, Loïc Coutte, Anne-Sophie Debrie, Nathalie Mielcarek, Jean-Claude Sirard, Stéphane Cauchi & Camille Locht. (2022) Live attenuated Bordetella pertussis vaccine candidate BPZE1 transiently protects against lethal pneumococcal disease in mice. Vaccine 40:11, pages 1555-1562.
Crossref
Crossref
Matthew Dryden, Michal Kantecki, Jean Li Yan, Gregory G. Stone, Heidi Leister-Tebbe & Mark Wilcox. (2022) Treatment outcomes of secondary bacteraemia in patients treated with ceftaroline fosamil: pooled results from six phase III clinical trials. Journal of Global Antimicrobial Resistance 28, pages 108-114.
Crossref
Crossref
I. N. Protasova, I. V. Feldblium, N. V. Bakhareva, O. P. Ovchinnikova & S. V. Domracheva. (2022) Preventive Efficacy of Pneumococcal Conjugated Vaccine (Population Aspects). Epidemiology and Vaccinal Prevention 20:6, pages 37-55.
Crossref
Crossref
Germaine Hanquet, Pavla Krizova, Tina Dalby, Shamez N. Ladhani, J. Pekka Nuorti, Kostas Danis, Jolita Mereckiene, Mirjam J. Knol, Brita A. Winje, Pilar Ciruela, Sara de Miguel, Maria Eugenia Portillo, Laura MacDonald, Eva Morfeldt, Jana Kozakova, Palle Valentiner-Branth, Norman K. Fry, Hanna Rinta-Kokko, Emmanuelle Varon, Mary Corcoran, Arie van der Ende, Didrik F. Vestrheim, Carmen Munoz-Almagro, Juan-Carlos Sanz, Jesus Castilla, Andrew Smith, Birgitta Henriques-Normark, Edoardo Colzani, Lucia Pastore-Celentano & Camelia Savulescu. (2022) Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe. Emerging Infectious Diseases 28:1, pages 137-138.
Crossref
Crossref
Emilio Letang, Natalia Rakislova, Miguel J Martinez, Juan Carlos Hurtado, Carla Carrilho, Rosa Bene, Inacio Mandomando, Llorenç Quintó, Tacilta Nhampossa, Valéria Chicamba, Elvira Luis, Mamudo R Ismail, Fabiola Fernandes, Cesaltina Lorenzoni, Luiz Ferreira, Monique Freire, Maria Teresa Rodrigo-Calvo, José Guerrero, Khátia Munguambe, Maria Maixenchs, Mireia Navarro, Isaac Casas, Lorena Marimon, Melania Ferrando, Eusebio Macete, Marcus Lacerda, Quique Bassat, Clara Menéndez & Jaume Ordi. (2021) Minimally Invasive Tissue Sampling: A Tool to Guide Efforts to Reduce AIDS-Related Mortality in Resource-Limited Settings. Clinical Infectious Diseases 73:Supplement_5, pages S343-S350.
Crossref
Crossref
Alex J. J. Lister, Cheng Foh Le, Eddy Seong Guan Cheah, Mohd Nasir Mohd Desa, David W. Cleary & Stuart C. Clarke. (2021) Serotype distribution of invasive, non-invasive and carried Streptococcus pneumoniae in Malaysia: a meta-analysis. Pneumonia 13:1.
Crossref
Crossref
Néhémie Nzoyikorera, Idrissa Diawara, Pablo Fresia, Fakhreddine Maaloum, Khalid Katfy, Kaotar Nayme, Mossaab Maaloum, Jennifer Cornick, Chrispin Chaguza, Mohammed Timinouni, Houria Belabess, Khalid Zerouali & Naima Elmdaghri. (2021) Whole genomic comparative analysis of Streptococcus pneumoniae serotype 1 isolates causing invasive and non-invasive infections among children under 5 years in Casablanca, Morocco. BMC Genomics 22:1.
Crossref
Crossref
Larisa Savrasova, Angelika Krumina, Hedija Cupeca, Indra Zeltina, Anita Villerusha, Ilze Grope, Ludmila Viksna, Elina Dimina & Sooria Balasegaram. (2021) Invasive Pneumococcal Disease in Latvia in PCV10 Vaccination Era, 2012–2018. Frontiers in Pediatrics 9.
Crossref
Crossref
Annelies Müller, Diana B. Schramm, Jackie Kleynhans, Linda de Gouveia, Susan Meiring, Alban Ramette, Anne von Gottberg & Lucy Jane Hathaway. (2021) Cytokine response in cerebrospinal fluid of meningitis patients and outcome associated with pneumococcal serotype. Scientific Reports 11:1.
Crossref
Crossref
Abdullah H. Baqui, Alain K. Koffi, Eric D. McCollum, Arunangshu D. Roy, Nabidul H. Chowdhury, Iftekhar Rafiqullah, Zabed B. Ahmed, Arif Mahmud, Nazma Begum, Salahuddin Ahmed, Rasheda Khanam, Meagan Harrison, Nicole Simmons, Shakir Hossen, Maksuda Islam, Abdul Quaiyum, William Checkley, Mathuram Santosham, Lawrence H. Moulton & Samir K. Saha. (2021) Impact of national introduction of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Bangladesh: Case-control and time-trend studies. Vaccine 39:40, pages 5794-5801.
Crossref
Crossref
Malte Kohns Vasconcelos, Katherine Loens, Louise Sigfrid, Elias Iosifidis, Cristina Epalza, Daniele Donà, Veerle Matheeussen, Savvas Papachristou, Emmanuel Roilides, Manuel Gijon, Pablo Rojo, Chiara Minotti, Liviana Da Dalt, Samsul Islam, Jessica Jarvis, Aggeliki Syggelou, Maria Tsolia, Maggie Nyirenda Nyang’wa, Sophie Keers, Hanna Renk, Anna-Lena Gemmel, Carmen D’Amore, Marta Ciofi degli Atti, Carmen Rodríguez-Tenreiro Sánchez, Federico Martinón-Torres, Sigita Burokienė, Tessa Goetghebuer, Vana Spoulou, Andrew Riordan, Cristina Calvo, Despoina Gkentzi, Markus Hufnagel, Peter J Openshaw, Menno D de Jong, Marion Koopmans, Herman Goossens, Margareta Ieven, Pieter L A Fraaij, Carlo Giaquinto, Julia A Bielicki, Peter Horby & Michael Sharland. (2021) Aetiology of acute respiratory infection in preschool children requiring hospitalisation in Europe—results from the PED-MERMAIDS multicentre case–control study. BMJ Open Respiratory Research 8:1, pages e000887.
Crossref
Crossref
Taito Kitano & Hirosato Aoki. (2021) The incremental burden of invasive pneumococcal disease associated with a decline in childhood vaccination using a dynamic transmission model in Japan: A secondary impact of COVID-19. Computers in Biology and Medicine 133, pages 104429.
Crossref
Crossref
Chiara Scelfo, Francesco Menzella, Matteo Fontana, Giulia Ghidoni, Carla Galeone & Nicola Cosimo Facciolongo. (2021) Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance. Vaccines 9:5, pages 420.
Crossref
Crossref
Nikolay I. Briko, Vladimir A. Korshunov & Kirill S. Lomonosov. (2021) Pneumococcal infection in Russia: state of the issue. Annals of the Russian academy of medical sciences 76:1, pages 28-42.
Crossref
Crossref
Clara Inés Agudelo, Carlos Castañeda-Orjuela, Maria Cristina de Cunto Brandileone, Gabriela Echániz-Aviles, Samanta Cristine Grassi Almeida, María Noemí Carnalla-Barajas, Mabel Regueira, Sofia Fossati, Pedro Alarcón, Pamela Araya, Carolina Duarte, Jacqueline Sánchez, Mirna Novas, Gilda Toraño-Peraza, Misladys Rodríguez-Ortega, Gustavo Chamorro-Cortesi, Anibal Kawabata, Gabriela García-Gabarrot, Teresa Camou, Enza Spadola, Daisy Payares, Ana Lucía Andrade, José Luis Di Fabio, Elizabeth Castañeda, A Corso, Paula Gaguetti, Omar Veliz, C S Pereira, D Napoli, M A Moscoloni, M L L Silva e Guerra, S Bokermann, Lincoln S do Prado, U J Días, J C Hormazabal, B Rojas, S Castro, D Ibáñez, J Fernandez, O Sanabria, J Moreno, Z Alarcón, M K Rodriguez, A Bautista, L P Solis, D S Apaza, M A Capote, J M Feris, D Cedano, Araceli Soto-Noguerón, Maria E Velázquez-Meza, Margarita Hernández-Salgado, M E León, Minako Nagai, Liliana Rojas, M L Vega, G P Giffoni & V Félix. (2021) The direct effect of pneumococcal conjugate vaccines on invasive pneumococcal disease in children in the Latin American and Caribbean region (SIREVA 2006–17): a multicentre, retrospective observational study. The Lancet Infectious Diseases 21:3, pages 405-417.
Crossref
Crossref
Heather L. Sings, Bradford D. Gessner, Matt D. Wasserman & Luis Jodar. (2021) Pneumococcal Conjugate Vaccine Impact on Serotype 3: A Review of Surveillance Data. Infectious Diseases and Therapy 10:1, pages 521-539.
Crossref
Crossref
Lilly M Verhagen, Ismar A Rivera-Olivero, Melanie Clerc, Mei Ling J N Chu, Jody van Engelsdorp Gastelaars, Maartje I Kristensen, Guy A M Berbers, Peter W M Hermans, Marien I de Jonge, Jacobus H de Waard & Debby Bogaert. (2021) Nasopharyngeal Microbiota Profiles in Rural Venezuelan Children Are Associated With Respiratory and Gastrointestinal Infections. Clinical Infectious Diseases 72:2, pages 212-221.
Crossref
Crossref
Naïm Ouldali, Emmanuelle Varon, Corinne Levy, François Angoulvant, Scarlett Georges, Marie-Cécile Ploy, Marie Kempf, Julie Cremniter, Robert Cohen, Daniel Levy Bruhl & Kostas Danis. (2021) Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study. The Lancet Infectious Diseases 21:1, pages 137-147.
Crossref
Crossref
A. Løvlie, D. F. Vestrheim, I. S. Aaberge & A. Steens. (2020) Changes in pneumococcal carriage prevalence and factors associated with carriage in Norwegian children, four years after introduction of PCV13. BMC Infectious Diseases 20:1.
Crossref
Crossref
Heather L. Platt, David Greenberg, Bruce Tapiero, Robert A. Clifford, Nicola P. Klein, David C. Hurley, Tulin Shekar, Jianing Li, Kim Hurtado, Shu-Chih Su, Katrina M. Nolan, Camilo J. Acosta, Richard D. McFetridge, Kara Bickham & Luwy K. Musey. (2020) A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants. Pediatric Infectious Disease Journal 39:8, pages 763-770.
Crossref
Crossref
Natalya M. Alyabyeva, Ekaterina A. Brzhozovskaya, Olga A. Ponomarenko & Anna V. Lazareva. (2020) Serotype distribution of Streptococcus pneumoniae isolated from children in Moscow before
and after introduction of 13-valent pneumococcal conjugate vaccination. Russian Pediatric Journal 23:3, pages 160-164.
Crossref
Crossref
Abdullah H. Baqui, Eric D. McCollum, Arif Mahmud, Arunangshu Roy, Nabidul H. Chowdhury, Iftekhar Rafiqullah, Syed Jafar Raza Rizvi, Nazma Begum, Dipak K. Mitra, Rasheda Khanam, Meagan Harrison, Salahuddin Ahmed, Md Hasanuzzaman, Hafizur Rahman, Maksuda Islam, Zabed B. Ahmed, Md Abdul Quaiyum, Alain Koffi, Nicole Simmons, William Checkley, Lawrence H. Moulton, Mathuram Santosham & Samir K. Saha. (2020) Population-based incidence and serotype distribution of invasive pneumococcal disease prior to introduction of conjugate pneumococcal vaccine in Bangladesh. PLOS ONE 15:2, pages e0228799.
Crossref
Crossref
Guillermo Ludwig, Selene Garcia-Garcia, Miguel Lanaspa, Pilar Ciruela, Cristina Esteva, Mariona Fernandez de Sevilla, Alvaro Diaz-Conradi, Carmina Marti, Montse Motje, Carme Galles, Montse Morta, Conchita Izquierdo, Fernando Moraga-Llop, Magda Campins, Luis Salleras, Mireia Jane, Angela Dominguez, Juan Jose Garcia-Garcia & Carmen Muñoz-Almagro. (2020) Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain. PLOS ONE 15:2, pages e0228612.
Crossref
Crossref
Charles Feldman & Ronald Anderson. (2020) Recent advances in the epidemiology and prevention of Streptococcus pneumoniae infections. F1000Research 9, pages 338.
Crossref
Crossref
J.C.De Moraes, X.M. Pérez Porcuna, J. Nieto-Guevara, A. Eisman, B. Torres, J.L. Gonzalez Redondo & X. Saez-Llorens. (2020) Vaccination with conjugate vaccines against pneumococcal disease: What really matters. Vacunas (English Edition) 21:1, pages 23-40.
Crossref
Crossref
J.C. De Moraes, X.M. Pérez Porcuna, J. Nieto-Guevara, A. Eisman, B. Torres, J.L. Gonzalez Redondo & X. Saez-Llorens. (2020) Vacunación frente a la enfermedad neumocócica con vacunas conjugadas: ¿qué es lo que verdaderamente importa?. Vacunas 21:1, pages 23-40.
Crossref
Crossref
D. E. Briles, J. C. Paton, R. Mukerji, E. Swiatlo & M. J. Crain. (2019) Pneumococcal Vaccines. Microbiology Spectrum 7:6.
Crossref
Crossref
D. E. Briles, J. C. Paton, R. Mukerji, E. Swiatlo & M. J. Crain. 2019. Gram-Positive Pathogens. Gram-Positive Pathogens
362
377
.
Naim Ouldali, Robert Cohen, Corinne Levy, Nathalie Gelbert-Baudino, Elisa Seror, François Corrard, François Vie Le Sage, Anne-Sylvestre Michot, Olivier Romain, Stéphane Bechet, Stéphane Bonacorsi, François Angoulvant & Emmanuelle Varon. (2019) Pneumococcal susceptibility to antibiotics in carriage: a 17 year time series analysis of the adaptive evolution of non-vaccine emerging serotypes to a new selective pressure environment. Journal of Antimicrobial Chemotherapy 74:10, pages 3077-3086.
Crossref
Crossref
Stefan M.T. Vestjens, Elisabeth A.M. Sanders, Bart J. Vlaminckx, Hester E. de Melker, Arie van der Ende & Mirjam J. Knol. (2019) Twelve years of pneumococcal conjugate vaccination in the Netherlands: Impact on incidence and clinical outcomes of invasive pneumococcal disease. Vaccine 37:43, pages 6558-6565.
Crossref
Crossref
Shannon C David, Zoe Laan, Vikrant Minhas, Austen Y Chen, Justin Davies, Timothy R Hirst, Shaun R McColl, Mohammed Alsharifi & James C Paton. (2019) Enhanced safety and immunogenicity of a pneumococcal surface antigen A mutant whole‐cell inactivated pneumococcal vaccine. Immunology & Cell Biology 97:8, pages 726-739.
Crossref
Crossref
Mark van der Linden, Matthias Imöhl & Stephanie Perniciaro. (2019) Limited indirect effects of an infant pneumococcal vaccination program in an aging population. PLOS ONE 14:8, pages e0220453.
Crossref
Crossref
Godwin Oligbu, Norman K. Fry & Shamez N. Ladhani. 2019. Streptococcus pneumoniae. Streptococcus pneumoniae
215
224
.
Sofia Maraki, Viktoria Eirini Mavromanolaki, Dimitra Stafylaki, George Hamilos & George Samonis. (2018)
The Evolving Epidemiology of Serotype Distribution and Antimicrobial Resistance of
Streptococcus pneumoniae
Strains Isolated from Adults in Crete, Greece, 2009–2016
. Infection & Chemotherapy 50:4, pages 328.
Crossref
Crossref